- Silverstein AM.Cellular versus humoral immunity: determinants and consequences of an epic nineteenth century battle. In: Silverstein AM, editors. A History of Immunology. 1st ed. New York: Academic Press Inc.; 1989. pp 38–58.
- Luke TC, Kilbane EM, Jackson JL, Hoffman SL.Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med2006;145: 599–609.
- Hung IF, To KK, Lee CK et al.Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis2011;52: 447–456.
- Köhler G, Milstein C.Continuous cultures of fused cells secreting antibody of predefined specificity. Nature1975;256: 495–497.
- Houdebine LM.Transgenic animal bioreactors. Transgenic Res2000;9: 305–320.
- Lillico SG, Sherman A, McGrew MJ et al.Oviduct-specific expression of two therapeutic proteins in transgenic hens. Proc Natl Acad Sci USA2007;104: 1771–1776.
- Hamers-Casterman C, Atarhouch T, Muyldermans S et al.Naturally occurring antibodies devoid of light chains. Nature1993;363: 446–448.
- van der Linder RH, Frenken LG, de Geus B et al.Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta1999;1431: 37–46.
- Kaplan MH.Immunologic relationship of group A streptococcal strains and human heart tissue. Possible significance for the pathogenesis of rheumatic fever. Am Heart J1963;65: 426–427.
- Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al.Guillain–Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Amer J Epidemiol1979;110: 105–123.
- Stowe J, Andrews N, Wise L, Miller E.Investigation of the temporal association of Guillain–Barré Syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol2009;169: 382–388.
- Halstead SB.Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res2003;60: 421–467.
- Dejnirattisai W, Jumnainsong A, Onsirisakul N et al.Cross-reacting antibodies enhance dengue virus infection in humans. Science2010;328: 745–748.
- Balsitis SJ, Williams KL, Lachica R et al.Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog2010;6: e1000790.
- Davis D, Chaudhri B, Stephens DM, Carne CA, Willers C, Lachmann PJ.The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens. J Gen Virol1990;71: 1975–1983.
- Taussig MJ, Lachmann PJ.Studies on antigenic competition. II. Abolition of antigenic competition by antibody against or tolerance to the dominant antigen: a model for antigenic competition. Immunol1972;22: 185–197.
- Throsby M, van den Brink E, Jongeneelen M et al.Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE2008;3: e3942.
- Sui J, Hwang WC, Perez S et al.Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol2009;16: 265–273.
- Friesen RH, Koudstaal W, Koldijk MH et al.New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLoS ONE2010;5: e9106.
- Suntharalingam G, Perry MR, Ward S et al.Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med2006;355: 1018–1028.
- Bargou R, Leo E, Zugmaier G et al.Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science2008;321: 974–977.
- Sharkey RM, Rossi EA, McBride WJ, Chang CH, Goldenberg DM.Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy. Semin Nucl Med2010;40: 190–203.
- Renegar K, Small PA Jr, Boykins LG, Wright PF.Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol2004;173: 1978–1986.
Emerging Microbes & Infections
Volume 1, 2012 - Issue 1